LL37 (5mg)

Key Features:

• LL37 (5mg) is an antimicrobial peptide that serves as a defense molecule against various pathogens, making it a valuable tool for immune research, infectious disease studies, and antimicrobial therapy.
• 99% Purity: Manufactured with 99% purity, LL37 (5mg) ensures the highest quality for scientific research into immune modulation, wound healing, and antimicrobial activity.
• Broad-Spectrum Antimicrobial Activity: LL37 is known for its ability to target a wide range of microorganisms, including bacteria, viruses, and fungi, making it an essential peptide for research into infection control and immunotherapy.
• Skin Regeneration and Wound Healing: LL37 has demonstrated significant potential in promoting wound healing, tissue regeneration, and skin repair, making it important for studies on dermal regeneration and chronic wound management.

Common Research Applications:

• Antimicrobial Activity: LL37 (5mg) is a key peptide in studies exploring its antibacterial, antiviral, and antifungal properties. Researchers focus on its ability to target pathogens and help the body defend against infections, especially in compromised immune states or in the context of chronic wounds and skin infections.
• Immune Modulation: LL37 is involved in immune regulation, modulating both innate and adaptive immune responses. Researchers study its role in immune defense, inflammatory regulation, and its potential as a therapeutic for autoimmune diseases and inflammatory disorders.
• Wound Healing and Skin Regeneration: This peptide is widely studied for its ability to promote wound healing, enhance skin regeneration, and support tissue repair. Studies focus on LL37 in dermatology, particularly for chronic wounds, burns, ulcers, and diabetic foot ulcers.
• Chronic Wounds and Infection Control: LL37 is investigated for its potential to treat chronic wounds and infections, where its ability to both promote healing and provide antimicrobial action can help mitigate the risks associated with wound infections.